Use of risperidone with a patient sensitive to conventional neuroleptic drugs
Alderman, C.P.; Fraser, C.D.
American Journal of Psychiatry 152(8): 1234-1235
1995
ISSN/ISBN: 0002-953X PMID: 7542839 Document Number: 451234
Document emailed within 1 workday
Related Documents
Gleason, P.P.; Conigliaro, R.L. 1997: Neuroleptic malignant syndrome with risperidone PharmacoTherapy 17(3): 617-621Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Reinares, M.; Martínez-Arán, A.; Colom, F.; Benabarre, A.; Salamero, M.; Vieta, E. 2000: Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients Actas Espanolas de Psiquiatria 28(4): 231-238
Lindholm, H.; Ljungberg, L. 1973: Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation Acta Psychiatrica Scandinavica. Supplementum 246: 52-56
Borison, R.L. 1996: Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing Clinical Therapeutics 18(4): 592-607; discussion 591
Kostowski, W.; Płaznik, A. 1984: Neuroleptic drugs Wiadomosci Lekarskie 37(3): 233-236
Loewenguth, C.; D'Amato, T.; Dalery, J. 1996: Neuroleptic drugs. Principles and rules of use La Revue du Praticien 46(6): 745-752
Krzymiński, S. 1989: Neuroleptic drugs in geriatric psychiatry Psychiatria Polska 23(1): 36-43
Fukuda, T.; Tsumagari, T. 1984: Effects of psychotropic drugs on lateral hypothalamic self-stimulation behavior in rats: correlation between self-stimulation behavior inhibition and striatal dopaminergic blockade by neuroleptic drugs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(6): 485-496
Erenberg, G. 1992: Treatment of Tourette syndrome with neuroleptic drugs Advances in Neurology 58: 241-243
Lavie, C.J.; Ventura, H.O.; Walker, G. 1986: Neuroleptic malignant syndrome: three episodes with different drugs Southern Medical Journal 79(12): 1571-1573
Peitl, M.V.ć; Pavlović, E.; Peitl, A.; Peitl, V. 2010: Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia Psychiatria Danubina 22(1): 123-124
Langer, G.; Sachar, E.J.; Gruen, P.H. 1978: Prolactin response to neuroleptic drugs in normal and schizophrenic subjects Psychopharmacology Bulletin 14(1): 8-9
Meltzer, H.Y.; Koenig, J.I.; Nash, J.F.; Gudelsky, G.A. 1989: Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs Acta Psychiatrica Scandinavica. Supplementum 352: 24-29
Sayed, Y.; Garrison, J.M. 1983: The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review Psychopharmacology Bulletin 19(2): 283-288
Georget, S.; Giesenfeld, A.; Gonzalvez, M.F.; Mangin, A.; Montaut, T.; Pareja, J.P.; Kahn, J.P. 1998: Survey of the quality of prescribing anticholinergic drugs in neuroleptic treated patients L'Encephale 24(2): 100-107
Bukowczyk, A.; Wasik, A.; Horodnicki, J. 1974: Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs Psychiatria Polska 8(2): 143-148
Ben Hadj Ali, B.; Dogui, M.; Ben Ammou, S.; Lôo, H. 1995: Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal L'Encephale 21(3): 209-215
McShane, R.; Keene, J.; Gedling, K.; Fairburn, C.; Jacoby, R.; Hope, T. 1997: Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up BMJ 314(7076): 266-270